• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number DL900F
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Thrombosis/Thrombus (4440)
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately one month of post deployment, the patient admitted to the hospital with lower extremity pain and swelling, in the patient consultation notes it was reported about 2 weeks ago, the patient was diagnosed with pulmonary embolism and extensive bilateral deep vein thrombosis.An ultrasound lower extremity was performed, and it revealed there was likely thrombosis from the inferior vena cava at the level of the filter down into the iliac veins and bilaterally into the lower extremities.The next day, a venogram was performed and it revealed thrombus was identified above and below the filter.Subsequently an angiojet was used to remove thrombus from the external iliac and common iliac veins bilaterally.Finally, additional tpa infusion therapy was initiated at 1mg per hour through each infusion catheter.The next day, a venogram was performed and it revealed the thrombus within the inferior vena cava including within the filter and superior to the filter has resolved.10cm long infusion catheters were placed in bilateral common femoral and external iliac veins for targeted tpn fusion.Continued infusion at the same rate was planned for overnight and a follow up venogram was planned.The next day, infrarenal inferior vena cava was now clear and filter shows no evidence of adjacent clot.Tpa infusion was stopped at this time.Therefore, the investigation is inconclusive as no objective evidence has been provided to confirm any alleged deficiency with the filter.Additionally, it can be confirmed that the patient experienced pulmonary embolism and thrombus above the filter post deployment.However, the relationship to the filter is unknown.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 03/2020).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis.At some time post filter deployment, it was alleged that the patient was diagnosed with pulmonary embolism and thrombus above the filter.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI FEMORAL SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key11973215
MDR Text Key255347680
Report Number2020394-2021-80495
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040801
UDI-Public(01)00801741040801
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDL900F
Device Catalogue NumberDL900F
Device Lot NumberGFBP3336
Was Device Available for Evaluation? No
Date Manufacturer Received05/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
LAMOTRIGINE AND OXYCODONE
Patient Outcome(s) Life Threatening; Other;
-
-